ConductScience.org, home

Gene · 51816

ADA2: adenosine deaminase 2

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. ADA2: adenosine deaminase 2. Genes, record 51816. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/51816

On this page

Gene

Symbol
ADA2
HGNC
Name
adenosine deaminase 2
HGNC
NCBI Gene ID
51816
NCBI Gene
HGNC ID
HGNC:1839
HGNC
Ensembl
ENSG00000093072
NCBI Gene
Aliases
ADGF, CECR1, IDGFL, PAN, SNEDS, VAIHS
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q9NZK5Adenosine deaminase 25112Ensembl, GeneID, HGNC

Source UniProt

Patents80

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
EP 4641202 A22025-10-29103Q9NZK5Espacenet
JP 2025534660 A2025-10-176Q9NZK5Espacenet
JP 2025147176 A2025-10-06226Q9NZK5Espacenet
JP 2025147176 A2025-10-06227Q9NZK5Espacenet
JP 2025147176 A2025-10-06228Q9NZK5Espacenet
JP 2025138725 A2025-09-251924Q9NZK5Espacenet
JP 2025138725 A2025-09-252735Q9NZK5Espacenet
JP 2025138725 A2025-09-252736Q9NZK5Espacenet
JP 2025529142 A2025-09-045820Q9NZK5Espacenet
EP 4601672 A12025-08-206Q9NZK5Espacenet

1 to 10 of 80

See all 80 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants2,177

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleADA2 papersNewest fiscal year
P30CA008748Cancer Center Support Grant352025
P30CA016672Cancer Center Support Grant222025
ZIAHG200372Genetics, Pathophysiology, and Treatment of Autoinflammatory and Autoimmune Diseases182025
P30AR070253Joint Biology Consortium Resource-based Center172025
P30CA093373Cancer Center Support Grant P30152025
P30CA006973Regional Oncology Research Center142025
P30CA068485Cancer Center Support Grant102025
R01AR073201Bridging the gap between GWAS and mechanism in arthritis102025
P30CA010815Consolidated Basic Cancer Research Program92025
UL1TR001863Yale Clinical and Translational Science Award92025

1 to 10 of 2,177Source NIH's project files

See all 2,177 nih grants

Papers4,003

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Combination pharmacotherapy for MASH: Potential synergistic approaches.Biochem Pharmacol202642767573PubTator, text miningPubMed
Schwannoma Likely Arising from the Pancreatic Head Nerve Plexus That Mimicked a Mucinous Cystic Neoplasm and Was Treated by Pancreaticoduodenectomy: A Case Report.Surg Case Rep202642719015PubTator, text miningPubMed
Nuclear Pan-Lysine Lactylation Immunoreactivity Is Associated With Poor Prognosis in Intrahepatic Cholangiocarcinoma.Hepatol Res202642663409PubTator, text miningPubMed
Erdheim-Chester Disease with Breast and Axillary Involvement Diagnosed by Ultrasound-Guided Biopsy: A Case Report and Literature Review.J Clin Med202642652736PubTator, text miningPubMed
Single-cell multi-omics reveals NUF2 as a potential biomarker associated with the high-lactylation malignant state in osteosarcoma.Int J Biol Markers202642605718PubTator, text miningPubMed
Pan-CDK and PLK1 inhibitors as a novel approach for targeted treatment of adrenocortical carcinomas.Eur J Endocrinol202642592842PubTator, text miningPubMed
Intratumor immune heterogeneity across simulated core biopsy sizes in non-small cell lung cancer: an exploratory study.Transl Lung Cancer Res202642582700PubTator, text miningPubMed
Evaluation of lymph node micrometastasis in oral squamous cell carcinoma - A retrospective histopathological study.J Oral Maxillofac Pathol202642569725PubTator, text miningPubMed
Not all NTRK fusions in mesenchymal neoplasia are driver events: implications on classification and targeted therapy.J Pathol Clin Res202642543793PubTator, text miningPubMed
DADA2 as a Model of Monogenic Immune Vasculopathy: From Immunopathogenesis to Precision Therapeutics.Biomolecules202642509849PubTator, text miningPubMed

1 to 10 of 4,003

See all 4,003 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/51816

GET https://conductscience.org/api/genes/v1/51816/patents?page=2